Nearly one-third of patients with irritable bowel syndrome (IBS) who underwent a novel behavior treatment developed by a UB behavioral scientist achieved significant relief within four weeks of beginning treatment.
These patients, called “rapid responders,” maintained their improvement at a three-month follow-up, despite reporting more severe IBS symptoms when they started the treatment.
Results also showed that the amount of “face time” spent with a therapist during the 10-week treatment regimen didn’t have an effect on rapid response.
The study is published in the current issue of the journal Clinical Gastroenterology and Hepatology.
“These results are important because conventional wisdom states that benefit from behavioral treatments is tied to the amount of treatment patients receive,” says first author Jeffrey Lackner, associate professor in the Department of Medicine, School of Medicine and Biomedical Sciences, and director of its Behavioral Medicine Clinic.